COVID-19 has been found to have a profound impact on the body, beyond the immediate symptoms of the virus itself. Researchers at Boston Children's Hospital have made a groundbreaking discovery that COVID-19 can reactivate dormant viruses in hospitalized patients.
Key Insights
The study revealed that the reactivation of Epstein-Barr and cytomegalovirus is associated with inflammation, rather than immunosuppression, and that the Anelloviridae viral family is strongly linked to long COVID and lasting disability. This finding offers a potentially important clue to understanding why some patients struggle to recover from COVID-19, and could pave the way for new treatments and therapies.










